AAM
ANIK icon

AMI Asset Management’s Anika Therapeutics ANIK Stock Holding History

AMI Asset Management’s Portfolio ANIK Stock Details ANIK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-322,062
Closed -$10.8M – 70
2018
Q4 		$10.8M Buy
322,062
+4,243
+1% +$153K 0.89% 41
2018
Q3 		$13.4M Sell
317,819
-26,849
-8% -$1.06M 0.91% 43
2018
Q2 		$11M Buy
344,668
+98,873
+40% +$4.07M 0.79% 52
2018
Q1 		$12.2M Sell
245,795
-30,246
-11% -$1.71M 0.87% 44
2017
Q4 		$14.9M Sell
276,041
-6,375
-2% -$353K 1.03% 41
2017
Q3 		$16.4M Sell
282,416
-26,643
-9% -$1.39M 1.16% 34
2017
Q2 		$15.2M Buy
309,059
+57,797
+23% +$2.66M 1.09% 38
2017
Q1 		$10.9M Sell
251,262
-66,623
-21% -$3.18M 0.82% 47
2016
Q4 		$15.6M Buy
317,885
+32,162
+11% +$1.49M 1.15% 38
2016
Q3 		$13.7M Sell
285,723
-48,845
-15% -$2.41M 0.94% 49
2016
Q2 		$17.9M Sell
334,568
-2,223
-0.7% -$105K 1.25% 33
2016
Q1 		$15.1M Sell
336,791
-53,992
-14% -$2.19M 1.03% 44
2015
Q4 		$14.9M Buy
390,783
+26,663
+7% +$1.02M 1.04% 38
2015
Q3 		$11.6M Buy
364,120
+3,327
+0.9% +$116K 0.89% 42
2015
Q2 		$11.9M Buy
360,793
+54,851
+18% +$1.96M 0.89% 42
2015
Q1 		$12.6M Buy
305,942
+33,980
+12% +$1.37M 0.98% 43
2014
Q4 		$11.1M Buy
271,962
+38,137
+16% +$1.49M 0.97% 39
2014
Q3 		$8.57M Buy
233,825
+50,331
+27% +$2.17M 0.84% 44
2014
Q2 		$8.5M Buy
183,494
+14,462
+9% +$643K 0.84% 42
2014
Q1 		$6.95M Buy
169,032
+10,945
+7% +$407K 0.71% 49
2013
Q4 		$6.03M Buy
+158,087
New +$4.88M 0.66% 48

Other funds holding ANIK

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
BTW
Boston Trust Walden Boston, Massachusetts $12.2B AUM 12.45% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

AMI Asset Management's ANIK Position: Q1 2019 in Review

AMI Asset Management sold out of Anika Therapeutics (ANIK) in Q1 2019, closing a stake of 322,062 shares — an estimated $10.8M sold.

AMI Asset Management first reported a position in ANIK in Q4 2013 and held it in 21 quarters. The position peaked at $17.9M in Q2 2016. 157 funds tracked by Wall St. Rank hold ANIK as of Q1 2019.

  • AMI Asset Management reported no remaining Anika Therapeutics position as of Q1 2019 after selling out during the quarter.
  • AMI Asset Management sold 322,062 Anika Therapeutics shares in Q1 2019, an estimated $10.8M.
  • AMI Asset Management first reported a position in Anika Therapeutics in Q4 2013 and held it in 21 quarters.
  • AMI Asset Management's Anika Therapeutics position peaked at $17.9M in Q2 2016.
  • 157 funds tracked by Wall St. Rank held Anika Therapeutics as of Q1 2019.

Based on AMI Asset Management's 13F filing for Q1 2019, filed 25 Apr 2019.